Authors:
Modan, B
Hartge, P
Hirsh-Yechezkel, G
Chetrit, A
Lubin, F
Beller, U
Ben-Baruch, G
Fishman, A
Menczer, J
Struewing, JP
Tucker, MA
Wacholder, S
Ebbers, SM
Friedman, E
Piura, B
Citation: B. Modan et al., Parity, oral contraceptives, and the risk of ovarian cancer among carriersand noncarriers of a BRCA1 or BRCA2 mutation, N ENG J MED, 345(4), 2001, pp. 235-240
Authors:
Menczer, J
Fintsi, Y
Arbel-Alon, S
Tell, L
Friedman, E
Jackman, A
Sherman, L
Citation: J. Menczer et al., The presence of HPV 16, 18 and p53 immunohistochemical staining in tumor tissue of Israeli Jewish women with cervical and vulvar neoplasia, EUR J GYN O, 21(1), 2000, pp. 30-34
Authors:
Menczer, J
Lerner-Geva, L
Bar Sade-Bruchim, R
Friedman, E
Citation: J. Menczer et al., Lack of the predominant BRCA1 and BRCA2 mutations in Jewish ovarian carcinoma patients who previously underwent ovulation induction, EUR J GYN O, 20(5-6), 1999, pp. 371-372
Authors:
Menczer, J
Livoff, A
Malinger, G
Girtler, O
Zakut, H
Citation: J. Menczer et al., Exaggerated placental site erroneously diagnosed as non-metastatic trophoblastic disease. A case report, EUR J GYN O, 20(2), 1999, pp. 115-116
Authors:
Menczer, J
Girtler, O
Zajdel, L
Glezerman, M
Citation: J. Menczer et al., Metastatic trophoblastic disease following partial hydatidiform mole: Casereport and literature review, GYNECOL ONC, 74(2), 1999, pp. 304-307